Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Rang in aandelen #27309
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Aandeelprijs
$0.89991249
Marktkapitalisatie
$33.67M
Verandering (1 dag)
-0.35%
Verandering (1 jaar)
7.33%
Land
TW
Handel Prince Pharmaceutical Co., Ltd. (6935)

Categorie

Aandelsplitsingen voor Prince Pharmaceutical Co., Ltd. (6935)
Het aandeel Prince Pharmaceutical Co., Ltd. (symbool: 6935) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 20, 2026.
Eén aandeel 6935 dat vóór Aug 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 6935.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten